Effects of VEGF on Proliferation, Apoptosis and Insulin Secretion in Rat Pancreatic Islet Cells

DENG Hao, DING Zhen-yu, Wang Chun. et al

Abstract

To investigate the effect of vascular endothelial growth factor (VEGF) on proliferation, apoptosis, insulin secretion and related gene expression in rat pancreatic islet cell (INS-1). Methods INS-1 cells were treated with different concentrations of VEGF. CCK-8 kit was used to detect the proliferation of INS-1 cells and the cell apoptosis were evaluated by using AnnexinⅤ and propidium iodide (PI) double staining kit. INS-1 cells were treated with VEGF and the standard glucose stimulated insulin secretion test with ELISA was conducted. The expression of related genes in pancreatic islets was detected by real-time quantitative PCR. The effect of VEGF on isulin protein expression was evaluated with Western blot. Results No significant changes (P＞0.05) in INS-1 cells were observed after treated with different concentrations of VEGF at 24 h, 48 h and 72 h. But when VEGF concentration were 80 ng/mL and 160 ng/mL, an inhibitory effect on cell apoptosis were noticed (PSur), inwardly rectifying potassium channel gene 6.2 (Kir6.2) as well as the release of insulin were noticed as the increasing of VEGF concentrations. The expression of glucokinase gene (GCK) first decreased and then increased, but the expression of glucose transporter gene 2 (Glut2) were increased first and then decreased. Conclusion VEGF inhibited the secretion of insulin from INS-1 cells in the high-glucose condition. Our study provides new clues to the function of VEGF on the glucose metabolism.

 

Keywords: VEGF, Glucose stimulated insulin secretion (GSIS), Insulin 

 

Full Text:

PDF


References


Xu Y, Wang L. He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA,2013;310(9) ;948-959.

Chen SC, Tseng CH. Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients. Rev Diabet Stud. 2013;10(2-3):88-100.

Huotari MA, Palgi J, Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINmSF cells; identification of betacellulin as a novel p-cell mitogen. Endocrinology» 1998; 139(4): 1494-1499.

Bao S, Song H, Tan M, etal. Group VIB Phospholipase A(2) promotes proliferation of INS-1 insulinoma cells and attenuates lipid peroxidation and apoptosis induced by inflammatory cytokines and oxidant agents. Oxid Med Cell Longev.2012; 2012:989372. doi: 10.1155/2012/989372,2004;8(27):5960-5961.

Huotari MA, Palgi J, Otonkoski Т. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINmSF cells: identification of betacellulin as a novel |3-cell mitogen. Endocrinology, 1998; 139(4); 1494-1499.

Quan X,Zhang L. Li Y. elal. TCF2 attenuates FFA-induced damage in islet (3-cells by regulating production of insulin and ROS. IntJ Mol Sci,2014; 15(8): 13317-13332.

Zhang SS, Hao E. Yu J. et al. Coordinated regulation by shp2 tyrosine phosphatase of signaling events controlling insulin bisynthesis in pancreatic (3-cells. PNAS.2009; 106 ( 18); 7531- 7536.

Santini E, Fallahi P, Ferrari SM, et al. Effect of PPAR-y activation and inhibition on glucose-stimulated insulin release in INS-le cells. Diabetes,2004;53(Suppl 3);S79-S83.

Stephens LA, Thomas HE, Ming L, et al. Tumor necrosis factor-a-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic £ cells. Endocrinology, 1999; 140 ( 7): 3219-3227.

WeiD, Li J, Shen M, et al. Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic ^-cells and islets enhance insulin secretion and confer protection against cytokin-induced cell death. Diabetes,2010;59(2):471-478.

Lin Y. Sun X. Qiu L. et al. Exposure to bisphenol A induces dyslunction ol insulin secretion and apotosis through the damage of mitochonfria in rat insulinoma (INS-1) cells. Cell Death Dis, 2013 Jan 17;4:e460. doi; 10. 1038/cddis. 2012. 206.

Motoshige H, Oyama K, Takahashi K, et al. Involvement of phosphatidylinositol 3-kinase/Akt pathway in gemcitabine- induced apoptosis-like cell death in insulinoma cell line INS-1. Biol Pharm Bull,2012;35(11): 1932-1940.

Ruszkowska-Ciastek B, Sokup A, Socha MW, et al. A preliminary evaluation of VEGF-A. VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus. J Zhejiang Univ Sci B,2014 ; 15(6):575-581.

Zorena K, My sliwska J. My s liwiec M, et al. Association between vascular endothelial growth factor and hypertension in children and adolescents type 1 diabetes mellitus. J Hum Hypertens, 2010; 24 (11); 755-762.

Sugahara KN, Teesalu T. Karmali PP. et al. Tissue- penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell.2009; 16(6):510-520.

Sugahara KN, Teesalu T, Karmali PP. et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science,2010;328(5981): 1031-1035.

Sharma A, Kapoor P. Gautam A, et al. Computational approach for designing tumor homing peptides. Sci Rep.2013; 3:1607. doi; 10. 1038/srep01607.

Zhu Z, Xie C, Liu Q. et al. The effect of hydrophilic chain length and iRGD on drug delivery from poly ( epsilon- caprolactone )-poly ( N-vinylpyrrolidone ) nanoparticles. Biomaterials,2011;32(35);9525-9535.

Puig-Saus C, Rojas LA, Laborda E, et al. iRGD tumor- penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Ther,2014 ;21 (8); 767-774.

Cai H, Yang H, Xiang B, et al. Selective apoptotic killing of solid and hematologic tumor cells by bombesin-targeted delivery of mitochondria-disrupting peptides. Mol Pharm, 2010; 7 ( 2 ) : 586-596.

Yang H, Liu S, Cai H, et al. Chondroitin sulfate as a molecular portal that preferentially mediates the apoptotic killing of tumor cells by penetratin-directed mitochondria- disrupting peptides. J Biol Chem,2010;285(33);25666-25676.

Laakkonen P. PorkkaK, Hoffman JA, etal. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat Med,2002;8(7):751-755.

Laakkonen P, Akerman ME, Biliran H, et al. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A,2004;101(25):9381- 9386.

Alberici L, Roth L, Sugahara KN, etal. De novo design of a tumor-penetrating peptide. Cancer Res,2013;73(2) :804-812.

Hu Q, Gu G, Liu Z, et al. F3 peptide-functionalized PEG- PLA nanoparticles со-administrated with tLyp-1 peptide for anti-glioma drug delivery. Biomaterials, 2013; 34 ( 4 ): 1135- 1145.

Yang ZZ. Li JQ. Wang ZZ, et al. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas. Biomaterials,2014 ;35( 19) :5226-5239.

He X, Na MH, Kim JS, et al. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor. Mol Pharm,2011 ;8(2) ;430-438.


Refbacks

  • There are currently no refbacks.